Fig. 7 | Scientific Reports

Fig. 7

From: Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA

Fig. 7

Analysis of protein-ligand docking for resveratrol and the marker genes AEBP1 in Macrophages.6. (A) The three-dimensional structure models showcase the interactions between AEBP1 and resveratrol. (B) The pose view provides a visual representation of the interaction sites, with hydrogen bonds depicted by black dashed lines between red atoms. (C) Immune-related genes IGHV3-74, IGHV3-33, IGHA1, IGKC, and IGLV1-44 were down-regulated by resveratrol treatment in human MASLD (GSE68421, n = 7). MASLD: metabolic dysfunction-associated steatotic liver disease.

Back to article page